Investigation of the safety profile , metabolic and pharmacodynamic effect of extract of Berberis aristata versus metformin tablet on blood glucose in patients with type 2 diabetic mellitus.

Physiology research center, Vice chancellor for Research and Technology of kerman medical University0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

试验速览

阶段: 2 期
状态: 已完成
发起方
入组人数: 60

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 years 至 75 years（—）
性别: All

入选标准

•Newly diagnosed type 2 diabetes based on ADA 2011 [14], 18-75 years old, Both sexes, Capable to swallow, No other tablet except metformine, No insulin therapy, No chronic inflammatory disease [17]
•Exclusion criteria: Fasting blood sugar more than 250 mg/dl, HbA1C more than 10%, Patients with chronic complications of diabetes, Pregnancy, Lactation, Known liver, renal or neurologic diseases (based on clinical examination, interview with patient or previously endorsed documents with the patients).

排除标准

未提供

研究者

发起方

Physiology research center, Vice chancellor for Research and Technology of kerman medical University

相似试验

已完成

不适用

Intravenous paracetamol in patients undergoing major abdominal surgeryMajor abdominal surgerypharamacokinetics and metabolismAnaesthesiology - Pain managementSurgery - Other surgerysepsis

ACTRN12608000028303Dunedin School of Medicine, University of Otago20

已完成

不适用

Influence of Metabolic Profiles on Drug Safety in Routine CareD50.0Y57.9D62D65.1D68.33D68.35D69.80D69.9G45G95.1H11.3H21.0H31.3H34.0H34.1H34.2H34.8H34.9H35.6H43.1H45.0H92.2I21I22I23I24I25I26I60I61I62I63I64I65I66I71I72I74I79.0I80I81I82I85.0I87.0J94.2K26.0K26.1K26.2K26.4K26.5K26.6K25.0K25.1K25.2K25.4K25.5K25.6K27.0K27.1K27.2K27.4K27.5K27.6K28.0K28.1K28.2K28.4K28.5K28.6K29.0K31.82K55.0K55.1K55.22K57.01K57.03K57.11K57.13K57.21K57.23K57.31K57.33K57.41K57.43K57.51K57.53K57.81K57.83K57.91K57.93K62.5K66.1K76.3K92.0K92.1K92.2M25.0M31.1M62.2N02R04R23.3R31R57.1R58S06.33S06.34S06.4S06.5S06.6S06.8S26.0S27.1S27.31S36.01S36.11S36.81T00.9T45.5T79.2T79.4Y57M60.1M60.8M60.9G72.0M62.8M62.9M79.1M79.7Iron deficiency anaemia secondary to blood loss (chronic)Drug or medicament, unspecifiedAcute posthaemorrhagic anaemiaHaemorrhagic condition, unspecifiedTransient cerebral ischaemic attacks and related syndromesVascular myelopathiesConjunctival haemorrhageHyphaemaChoroidal haemorrhage and ruptureTransient retinal artery occlusionOther retinal artery occlusionsOther retinal vascular occlusionsRetinal vascular occlusion, unspecifiedRetinal haemorrhageVitreous haemorrhageVitreous haemorrhage in diseases classified elsewhereOtorrhagiaThrombotic microangiopathySubsequent myocardial infarctionCertain current complications following acute myocardial infarctionOther acute ischaemic heart diseasesChronic ischaemic heart diseaseSubarachnoid haemorrhageIntracerebral haemorrhageOther nontraumatic intracranial haemorrhageStroke, not specified as haemorrhage or infarctionOcclusion and stenosis of precerebral arteries, not resulting in cerebral infarctionOcclusion and stenosis of cerebral arteries, not resulting in cerebral infarctionAortic aneurysm and dissectionOther aneurysm and dissectionArterial embolism and thrombosisAneurysm of aorta in diseases classified elsewherePhlebitis and thrombophlebitisOther venous embolism and thrombosisOesophageal varices with bleedingPostthrombotic syndromeHaemothoraxAcute haemorrhagic gastritisAcute vascular disorders of intestineChronic vascular disorders of intestineHaemorrhage of anus and rectumHaemoperitoneumInfarction of liverHaematemesisMelaenaGastrointestinal haemorrhage, unspecifiedHaemarthrosisIschaemic infarction of muscleRecurrent and persistent haematuriaHaemorrhage from respiratory passagesSpontaneous ecchymosesUnspecified haematuriaHypovolaemic shockPulmonary embolismPortal vein thrombosisHaemorrhage, not elsewhere classifiedEpidural haemorrhageTraumatic subdural haemorrhageTraumatic subarachnoid haemorrhageOther intracranial injuriesInjury of heart with haemopericardiumTraumatic haemothoraxMultiple superficial injuries, unspecifiedAnticoagulantsTraumatic secondary and recurrent haemorrhageOther and unspecified drugs and medicamentsInterstitial myositisOther myositisMyositis, unspecifiedDrug-induced myopathyOther specified disorders of muscleDisorder of muscle, unspecifiedMyalgiaFibromyalgiaCerebral infarctionAcute myocardial infarctionTraumatic shockCentral retinal artery occlusion

DRKS00013909Bundesinstitut für Arzneimittel und Medizinprodukte10,782

进行中（未招募）

1 期

Seguridad, efecto hemostático y metabólico y eficacia anticonceptiva de 2 posologías del anticonceptivo oral monofásico basado en la combinación etinilestradiol 0'03 mg/acetato de clormadinona 2 mg (CG5025). Safety, hemostatic and metabolic effects and contraceptive efficacy of an oral monophasic contraceptive containing 0.03 mg ethinylestradiol and 2 mg chlormadinone acetate (CG5025) used in two different regimens of intakeAnticoncepción (Wish of contraception).

EUCTR2004-002076-42-ESaboratorios Andrómaco S.A.1,012

招募中

1 期

Evaluation of safety and pharmacokinetic parameters of the PTI5803 productEpilepsy

CTIS2024-512472-35-00Panntherapi8

进行中（未招募）

不适用

utritional and Laboratory Parameters in Obese Patients Undergoing Two Hypocaloric Diets: Traditional Diet and Dukan DietC18.654.726.500Obesity

RBR-7fb2mmniversidade Federal de são Paulo -UNIFESP